Loading...
Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients
BACKGROUND: Prolonging kidney transplant survival is an important clinical priority. Induction immunosuppression with antibody therapy is recommended at transplantation and non‐depleting interleukin‐2 receptor monoclonal antibodies (IL2Ra) are considered first line. It is suggested that recipients a...
Na minha lista:
| Udgivet i: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Ltd
2017
|
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6464766/ https://ncbi.nlm.nih.gov/pubmed/28073178 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD004759.pub2 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|